The TNFRSF1B c.587T>G genotype did not alter the responses to 5-fluorouracil and cisplatin and survival of patients with esophageal carcinomas [31], but its role in the CM outcome is still unknown. This evidence concerns the gene TNFRSF1B and carcinoma of esophagus.